The most useful questions to ask are about who qualifies for PSEN1 testing, what a result does and doesn't tell you, and how it affects relatives. PSEN1 is a gene linked to early-onset familial Alzheimer's disease, and testing it is a narrow, specific decision rather than a routine checkup. Dementia symptoms appearing decades earlier than typical, especially alongside a family history spanning multiple generations, are what usually prompt a doctor to raise PSEN1 testing. The questions below cover eligibility, what a positive or negative result actually means, who else in the family should know, and what to ask a genetic counselor before agreeing to the test.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Am I or my family member actually a candidate for this test?
- What does a positive result actually mean — and what can't it tell you?
- What should I ask a genetic counselor before testing?
- How should I prepare for the emotional impact of the result?
- What does this mean for my other blood relatives?
- Frequently Asked Questions
Am I or my family member actually a candidate for this test?
PSEN1 testing is reserved for two groups: people already showing dementia symptoms with a family history of early-onset Alzheimer's across multiple generations, or asymptomatic adults whose relative already carries a known PSEN1 variant, according to Pathology Tests Explained. It is not offered as a general screening tool, and it is not used to check risk for the more common, later-onset form of Alzheimer's. PSEN1 is the single most frequent cause of early-onset familial Alzheimer's disease (EOFAD), responsible for an estimated 20% to 70% of EOFAD cases depending on the lab and patient series, with symptoms typically starting in the 40s to early 50s, per ARUP Laboratories.
Because it is the most common of the three EOFAD genes, a GeneReviews-based protocol recommends testing PSEN1 first when a symptomatic patient's history fits this pattern, Pathology Tests Explained notes. For a relative who has no symptoms but wants to know their own risk, predictive testing generally requires that the family's specific PSEN1 variant already be identified in an affected relative first, according to the Dominantly Inherited Alzheimer Network at Washington University. Without that confirmed variant on record, there is nothing specific to test an at-risk relative against.
What does a positive result actually mean — and what can't it tell you?
A positive PSEN1 result strongly predicts that EOFAD will eventually develop, but it cannot tell you exactly when symptoms will start or how severe they will be. Penetrance, onset age, and rate of progression all vary even among members of the same family carrying the identical mutation, Pathology Tests Explained reports. PSEN1-linked EOFAD is inherited in an autosomal dominant pattern, meaning each child of an affected parent has a 50% chance of inheriting the variant, regardless of which parent carries it.
That 50% figure applies per child, independently — it does not average out or guarantee that exactly half of a family's children will be affected. Equally important: a negative result does not clear a family of inherited risk. Standard testing panels only detect variants within the coding regions and intron-exon boundaries of the genes tested, so other mutation types or genes tied to early-onset Alzheimer's can be missed entirely, per Pathology Tests Explained.
What should I ask a genetic counselor before testing?
Genetic counseling before and after the test is a standard part of the process, not an optional add-on. One insurer's medical policy makes this explicit by conditioning coverage on documented pre- and post-test counseling with an appropriate provider, according to Highmark's medical policy. Ask the counselor directly whether a positive result changes anything about treatment. Genetic counselors are advised to clarify, before predictive testing, that there are currently no treatments that prevent onset or halt progression of PSEN1-linked Alzheimer's, per guidance from the University of Washington Memory and Brain Wellness Center.
That means a positive result confirms risk without opening a new treatment pathway. Also ask what legal protections apply to a genetic result. The 2008 Genetic Information Nondiscrimination Act (GINA) protects against genetic discrimination in employment and health insurance in the US, but it does not extend to life, disability, or long-term care insurance, according to a review cited in PMC. A counselor should be asked specifically about those uncovered policy types before testing proceeds.
How should I prepare for the emotional impact of the result?
A negative result is not automatically a relief. A study measuring emotional response found that people who tested negative for a PSEN1/EOFAD variant reported testing-specific distress at levels similar to those who tested positive, according to a review linked to the European Journal of Human Genetics. Survivor guilt, unresolved uncertainty about other relatives, and shifted family dynamics can all follow a negative result.
Some people choose not to finish the process at all. A related research protocol noted that some participants withdrew before testing after becoming more aware of the possible negative consequences, per the same Erasmus University-linked review. Asking a counselor what withdrawal looks like, and confirming that it carries no penalty, is a reasonable question to raise upfront.
What does this mean for my other blood relatives?
Because PSEN1 is inherited, a result reaches beyond the person tested. Siblings, children, and other close blood relatives of someone who tests positive each carry their own independent risk, and a confirmed family variant is what makes predictive testing possible for them, per the Dominantly Inherited Alzheimer Network.
Worth asking before testing: who in the family will be told the result, and when. A result affects decisions a relative might make about their own testing, family planning, or long-term care planning, even if that relative isn't present for the conversation. Deciding in advance how and when to share results — and with whom — avoids leaving that decision for a moment of crisis.
Frequently Asked Questions
Can PSEN1 testing predict when symptoms will start?
No. A positive result confirms elevated risk, but onset age, severity, and progression speed vary even within the same family, per Pathology Tests Explained.
Does a negative PSEN1 result rule out inherited Alzheimer's risk?
No. Standard panels only cover coding regions and intron-exon boundaries, so other mutation types or genes can still carry risk, according to Pathology Tests Explained.
Is genetic counseling required for PSEN1 testing?
It's treated as standard practice, and at least one insurer conditions coverage on documented pre- and post-test counseling, per Highmark's medical policy.
Does GINA protect against all insurance discrimination based on a PSEN1 result?
No. GINA covers employment and health insurance but not life, disability, or long-term care insurance, according to PMC.
